Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.
about
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors.Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor.Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myelomaThe human and murine hematopoietic stem cell niches: are they comparable?How do we mobilize and collect autologous peripheral blood stem cells?Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure.Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization.Blood graft composition after plerixafor injection in patients with NHL.Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.Peripheral blood stem cell collection in low-weight children: retrospective comparison of two apheresis devices.UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor.Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs.Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers.
P2860
Q33411277-71E0C7C4-4700-41B5-992D-6CC79DD72561Q34265754-B7E5A2C5-D9BC-4515-8445-5E404C72DEA6Q36569033-A3AC8CD7-4E6F-48BE-8EA4-A4A230569A69Q37335216-D1EEB1DF-B494-4524-AA82-EB749D684554Q38682154-D4FCB559-0D58-4E91-9A1F-CAE7228FDA15Q38978669-68F32195-62E7-40F5-879D-2BA0931D26C7Q41685138-ABFABE4D-446F-490F-842D-C2FBEA6B3495Q44256421-89EA72A1-49E5-4C56-B9D4-6A27EC545E51Q44353274-EF7C4F1E-8C3B-4BCE-AD8C-215F8A355797Q44607102-F08E3078-7665-40DE-A791-1D4D45A47103Q44899898-1BB833C2-8105-4BA7-BD4B-7DE3F347297FQ48251584-E2C20ACC-EBA5-4FAF-B6B1-871DF35519FEQ48251589-B0D70AF6-93AF-402F-B993-878CDA68443BQ51010848-C0EBD540-C3CA-49B8-8565-A570AB864CB9Q51776428-562D0FCC-6C25-4C05-8DC3-6541A1C3F434Q53508311-23D2A3F2-8D78-4D39-BFAF-2EE74FF65782Q54582789-D00AF72B-178C-4D17-B988-686D575005B9
P2860
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@en
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@nl
type
label
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@en
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@nl
prefLabel
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@en
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@nl
P2093
P2860
P356
P1476
Preemptive dosing of plerixafo ...... day 5 of G-CSF administration.
@en
P2093
C Gasparetto
C McDonald
D A Rizzieri
K M Sullivan
M E Horwitz
P2860
P2888
P304
P356
10.1038/BMT.2011.217
P407
P577
2011-11-14T00:00:00Z